本综述系统探讨了超越传统生物制剂（如抗TNF、抗整合素等）和小分子药物（如JAK抑制剂、S1P受体调节剂）的IBD新兴治疗策略，涵盖细胞与基因疗法、微生物组干预、靶向免疫调节（如治疗性肽段、RNA药物及疫苗）以及整合医学模式（包括饮食干预、营养补充与 ...

A recent study published in the journal Gastroenterology focuses on the growth in advanced training the field of inflammatory bowel disease. Here are seven things to know from the study. • The ...

Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes ...

为解决炎症性肠病（IBD）中免疫球蛋白（Ig）包被菌群失衡与黏膜免疫紊乱的问题，研究人员开展Lactobacillus johnsonii来源胞外囊 ...

Inflammatory Bowel Disease (IBD) is a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms. Crohn's Disease and Ulcerative Colitis -- the ...

Although inflammatory bowel disease (IBD) starts in the gut, it doesn’t always stay there. According to a 2015 study in the journal Inflammatory Bowel Disease, up to 47% of people with IBD will ...

国庆长假将至，很多人已经迫不及待地规划出行计划。然而，对于炎症性肠病（IBD）患者来说，旅行却常常是一场“心理与 ...